BASQUIN BCD
BASQUIN BCD
Authorised
- Clostridium perfringens, type B, strain ATCC 3626, Inactivated
- Clostridium perfringens, type C, strain ATCC 3628, Inactivated
- Clostridium perfringens, type D, strain ATCC 3629, Inactivated
- Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, beta toxoid
- Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, epsilon toxoid
Product identification
Medicine name:
BASQUIN BCD
Active substance:
- Clostridium perfringens, type B, strain ATCC 3626, Inactivated
- Clostridium perfringens, type C, strain ATCC 3628, Inactivated
- Clostridium perfringens, type D, strain ATCC 3629, Inactivated
- Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, beta toxoid
- Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, epsilon toxoid
Target species:
-
Sheep (lamb)
-
Goat (kid)
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Clostridium perfringens, type B, strain ATCC 3626, Inactivated
-
Clostridium perfringens, type C, strain ATCC 3628, Inactivated
-
Clostridium perfringens, type D, strain ATCC 3629, Inactivated
-
Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, beta toxoid10.00Toxic unit(s)2.00millilitre(s)
-
Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, epsilon toxoid5.00Toxic unit(s)2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Sheep (lamb)
-
Meat and offal0day
-
- Goat (kid)
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- CZ Vaccines S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Ovejero S.A.
Responsible authority:
- Spanish Agency For Medicines And Health Products
Authorisation number:
- 3348 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?: